PACTR202006677216503已完成3 期
Acute melatonin ingestion reduced muscle damage, inflammation and oxidative stress after an exhaustive exercise in obese patients.
Research Laboratory molecular bases of human pathology LR19ES13 Faculty of medicine of Sfax0 个研究点目标入组 32 人开始时间: 2020年6月4日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
Inflammatory responses, muscle damage and biomarkers of oxidative stress have been assessed before and after HIIE. MLT ingestion attenuated the increase of inflammation in Leucocytes (-6.63%; p<0.01), Neutrophils (-8.14%; p<0.01), and C-reactive protein (-9.1%; p<0.001)), hepatic and muscle damage in ASAT (-3.52%; p<0.001), ALAT (-3.47%; p<0.001) and Creatine kinase (-3.94%; p<0.05) and the lipid and protein peroxidation (malondialdehyde (-11.01%; p<0.05), AOPP (-16.86%; p<0.001)). Additionally, the enzymatic antioxidant biomarkers were enhanced (Thiol (+23.81%; p<0.01), Catalase (+20.17%; p<0.01)) in the MLT session compared to the placebo session after HIIE.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)(—)
- 性别
- All
入选标准
- •Age 20-50 years
- •- BMI> 30 kg / m2
- •- Circumference of height> 94 cm (man)
- •- Circumference of the waist> 80 cm (woman)
- •- No use of medication
- •- No regular exercise for at least 6 months
排除标准
- •- Against indication to the effort
- •- Antecedent injury
- •- Cardiorespiratory disease
- •- Diabetes type 2
研究者
相似试验
已完成
不适用
Effects Antioxidants Supplementation on Muscular Function Patients Facioscapulohumeral Dystrophy (FSHD)Facioscapulohumeral Muscular DystrophyNCT01596803University Hospital, Montpellier54
已完成
不适用
Sport Therapy and Osteopathy Manipulative Treatment in ALSAmyotrophic Lateral SclerosisNCT02548663University of Milano Bicocca30
已完成
不适用
Strength Training Induced Alterations in Markers of Immune FunctionInflammationNCT01450852Louisiana State University Health Sciences Center in New Orleans42
已完成
不适用
Antioxidants Vitamins and Muscle DamageOxidative StressNCT05127928Universidad Europea de Madrid18
已完成
不适用
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease PatientsPeripheral Artery DiseasePeripheral Arterial DiseaseNCT03506633University of Nebraska14
